S
Sana Biotechnology
Seattle, United States
Founded 2018 NASDAQ: SANA
Gene Therapy Delivery Cell Therapy Nano Nanomedicine Synthetic Biology Protein Nanoparticles Nano-Bio
About
Biotechnology company engineering cells to treat disease using in vivo and ex vivo approaches
Company Details
- Type
- public
- Employees
- 500+
- Funding
- Public
Key Products
- Hypoimmune Cells
- Fusogens
- In Vivo Gene Therapy